İrbesartan ve Hidroklorotiyazidin CE-DAD ile Tabletlerden Eşzamanlı Miktar Tayin
İ rbesartan ve hidroklorotiazidin tabletlerde eş zamanlı analizi için bir elektroforetik yöntem geliştirilmiştir. %10 metanol içeren 10 mM borat pH 9.0 çalışma tamponu olarak kullanılmıştır. Bileşikler 6 dakikadan daha düşük sürede ayrılmıştır. Tayin sınırı LOQ değerleri irbesartan için 3.370×10-7 M 0.144 µg/mL ve hidroklorotiazid için 3.140×10-7 M 0.094 µg/mL ’dir. Yöntem, irbesartan ve irbesartan/hidroklorotiazidi birlikte içeren tabletlere yaklaşık %100 gibi bir geri kazanımla başarılı bir şekilde uygulanmıştır
Simultaneous Determination of Irbesartan and Hydrochlorothiazide in Tablets by CE-DAD
Acapillary electrophoretic method was developed and validated for the simultaneous determination of irbesartan and hydrochlorothiazide in tablets. The run buffer was used 10 mM borate buffer containing 10% methanol pH 9.0 . Compounds were separated less than 6 minutes. The limit of quantification LOQ values were 3.370×10-7 M 0.144 μg/mL and 3.140×10-7 M 0.094 μg/mL for irbesartan and hydrochlorothiazide, respectively. The method was applied successfully to both irbesartan and irbesartan/hydrochlorothiazide combi- ned tablets with good recoveries almost 100%.
___
- 1. M. Burnier, H.R. Brunner, Angiotensin II receptor antagonists, Lancet, 355 (2000), 637-345.
- 2. A. Lant, Diuretics. Clinical pharmacology and therapeutic use (Part II), Drugs, 29(2) (1985), 162-188.
- 3. I. Albero, V. Rodenas, S. Garcia, C. Sanchez-Pedreno, Determination of irbesartan in the presence of hydrochlorothiazide by derivative spectrophotometry, J. Pharm. Biomed. Anal., 29 (2002) 299-305.
- 4. N. Erk, Three new spectrophotometric methods applied to the simultaneous determination of hydrochlorothiazide and irbesartan, Pharmazie, 58 (2003) 543-548.
- 5. Y.M. Fayez, Simultaneous determination of some antihypertensive drugs in their binary mixture by novel spectrophotometric methods, Spectrochim. Acta, Part A: Mol. Biomol. Spectr., 132 (2014) 446–451.
- 6. J. Joseph-Charles, S. Brault, C. Boyer, M.-H. Langlois, L. Cabrero, J.-P. Dubost, Simultaneous Determination of Irbesartan and Hydrochlorothiazide in Tablets by Derivative Spectrophotometry, Anal. Lett., 36 (2003) 2485 -2495.
- 7. C. Vetuschi, A. Giannandrea, G. Carlucci, P. Mazzeo, Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometry, Il Farmaco, 60 (2005) 665–670.
- 8. A.M. Alanazi, A.S. Abdelhameed, N.Y. Khalil, A.A. Khan, I.A. Darwish, HPLC method with monolithic column for simultaneous determination of irbesartan and hydrochlorothiazide in tablets, Acta Pharm., 64 (2014) 187–198.
- 9. F.Coudore, L. Harvard, S. Lefeuvre, E.M. Billaud, P. Beaune, G. Bobrie, M. Azizi, P. Prognon, S. Laurent, HPLC–DAD Analysis of Hydrochlorothiazide and Irbesartan in Hypertensive Patients on Fixed-Dose Combination Therapy, Chromatographia, 74 (2011) 559–565.
- 10. A.A. Elshanawane, L. M. Abdelaziz, M.M. Kamal, H.M. Hafez, Quantitative determination of four angiotensin-II receptor antagonists in presence of hydrochlorothiazide by a gradient technique HPLC in their pharmaceutical preparations, J. Liq. Chromatogr. Related Technol., 37 (2014) 171–186.
- 11. N. Erk, Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatography, J. Chromatogr. B, 784 (2003) 195- 201.
- 12. H.M. Hafez, A.A. Elshanawane, L.M. Abdelaziz, M.M. Kamal, Quantitative Determination of three Angiotensin-II-receptor Antagonists in Presence of Hydrochlorothiazide by RP-HPLC in their Tablet Preparations, Iranian J. Pharma. Res., 12 (2013) 635- 643.
- 13. A.S. Khodke, L.V. Potale, M.C. Damle, K.G. Bothara, A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazide, Pharm. Methods, 2(1) (2010) 39- 43.
- 14. S. Koyutürk, N. Ö. Can, Z. Atkoşar, G. Arlı., A novel dilute and shoot HPLC assay method for quantification of irbesartan and hydrochlorothiazide in combination tablets and urine using second generation C18- bonded monolithic silica column with double gradient elution, J. Pharm. Biomed. Anal., 97 (2014) 103-110.
- 15. X. Qiu, Z. Wang, B. Wang, H. Zhan, X. Pan, R. Xu, Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence study, J. Chromatogr. B, 957 (2014) 110-115.
- 16. L.F. Tutunji, M.F. Tutunji, M.I. Alzoubi, M.H. Khabbas, A.I. Arida, Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studies, J. Pharm. Biomed. Anal., 51 (2010) 985-990.
- 17. Z. Vujic, N. Mulavdic, M. Smajic, J. Brboric, P. Stankovic, Simultaneous Analysis of Irbesartan and Hydrochlorothiazide:An Improved HPLC Method with the Aid of a Chemometric Protocol, Molecules, 17 (2012) 3461-3474.
- 18. R. Zhang, X. Chen, Q. Li, W. Liu, W. Yang, K. Bi, L. Sun, Liquid chromatography coupled with mass spectrometry method for the simultaneous quantification of irbesartan and hydrochlorothiazide in human plasma, J. Chin. Pharm. Sci., 20 (2011) 360– 367.
- 19. S. Hillaert, W. Van den Boosche, Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis, J. Pharm. Biomed. Anal., 31 (2003) 329-339.
- 20. ICH, Q2(R1), Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology in International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, (2005).